Cargando…

The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Pan, Fengfeng, Lu, Yan, Huang, Qi, Xie, Fang, Yang, Jingye, Guo, Qihao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436434/ https://www.ncbi.nlm.nih.gov/pubmed/37596644 http://dx.doi.org/10.1186/s40035-023-00371-z

Ejemplares similares

Correlation Between Urine Formaldehyde and Cognitive Abilities in the Clinical Spectrum of Alzheimer’s Disease
por: Wang, Ying, et al.
Publicado: (2022)

Systematic evaluation of urinary formic acid as a new potential biomarker for Alzheimer’s disease
por: Wang, Yifan, et al.
Publicado: (2022)

Integrated algorithm combining plasma biomarkers and cognitive assessments accurately predicts brain β-amyloid pathology
por: Pan, Fengfeng, et al.
Publicado: (2023)

Cellular transcriptional alterations of peripheral blood in Alzheimer’s disease
por: Song, Liting, et al.
Publicado: (2022)

Serum sirtuin1: a potential blood biomarker for early diagnosis of Alzheimer’s disease
por: Wang, Jia, et al.
Publicado: (2023)

Potential biomarkers of Alzheimer’s disease and cerebral small vessel disease
por: Zou, Chun, et al.
Publicado: (2022)

Alzheimer’s disease and blood-based biomarkers – potential contexts of use
por: Zvěřová, Martina
Publicado: (2018)

REPS1 as a Potential Biomarker in Alzheimer’s Disease and Vascular Dementia
por: Luo, Jiefeng, et al.
Publicado: (2022)

Blood biomarkers for Alzheimer’s disease
por: Lovestone, Simon
Publicado: (2014)

Blood Biomarkers in Alzheimer’s Disease
por: Mandal, Pravat K., et al.
Publicado: (2023)

Discovery of Novel Biomarkers for Alzheimer's Disease from Blood
por: Long, Jintao, et al.
Publicado: (2016)

Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease
por: Esteras, Noemí, et al.
Publicado: (2013)

Identification of Blood Biomarkers for Alzheimer's Disease Through Computational Prediction and Experimental Validation
por: Yao, Fang, et al.
Publicado: (2019)

GPR160 is a potential biomarker associated with prostate cancer
por: Guo, Wanjing, et al.
Publicado: (2021)

Association between handgrip strength and cognition in a Chinese population with Alzheimer’s disease and mild cognitive impairment
por: Su, Hang, et al.
Publicado: (2021)

Blood‐based biomarkers for Alzheimer's disease
por: Leuzy, Antoine, et al.
Publicado: (2021)

Diagnostic Blood Biomarkers in Alzheimer’s Disease
por: Park, Jung Eun, et al.
Publicado: (2022)

Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use
por: d’Abramo, Cristina, et al.
Publicado: (2020)

Impaired type I interferon signaling activity implicated in the peripheral blood transcriptome of preclinical Alzheimer's disease
por: Song, Liting, et al.
Publicado: (2022)

Impact of adenomyosis on the outcome of in vitro fertilization
por: Qin, Yaoqin, et al.
Publicado: (2023)

Cognitive Decline in Patients with Alzheimer’s Disease and Its Related Factors in a Memory Clinic Setting, Shanghai, China
por: Zhao, Qianhua, et al.
Publicado: (2014)

Emotional Comparison Between Semantic Dementia and Alzheimer's Disease
por: Wang, Ping, et al.
Publicado: (2021)

Identification of Potential Biomarkers and Related Transcription Factors in Peripheral Blood of Tuberculosis Patients
por: Xie, Longxiang, et al.
Publicado: (2020)

Plasma Aβ as a biomarker for predicting Aβ-PET status in Alzheimer’s disease：a systematic review with meta-analysis
por: Cheng, Lizhen, et al.
Publicado: (2022)

Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?
por: Jellinger, Kurt A, et al.
Publicado: (2008)

Screening and Identification of Potential Peripheral Blood Biomarkers for Alzheimer’s Disease Based on Bioinformatics Analysis
por: Wang, Xin, et al.
Publicado: (2020)

Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer’s Disease
por: Sánchez-Campillo, María, et al.
Publicado: (2019)

A metabolomic approach to identifying biomarkers in blood of Alzheimer's disease
por: Lin, Chia‐Ni, et al.
Publicado: (2019)

Effects of Vascular Risk Factors on the Association of Blood-Based Biomarkers with Alzheimer’s Disease
por: Hoost, SS, et al.
Publicado: (2023)

Amyloid blood biomarker detects Alzheimer's disease
por: Nabers, Andreas, et al.
Publicado: (2018)

Blood-based molecular biomarkers for Alzheimer’s disease
por: Zetterberg, Henrik, et al.
Publicado: (2019)

Identifying Protein Biomarkers in Blood for Alzheimer's Disease
por: Zhao, Tianyi, et al.
Publicado: (2020)

Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
por: Montoliu-Gaya, Laia, et al.
Publicado: (2021)

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
por: Hansson, Oskar, et al.
Publicado: (2022)

Clinical Features and Potential Mechanisms Relating Neuropathological Biomarkers and Blood-Brain Barrier in Patients With Alzheimer’s Disease and Hearing Loss
por: Zhang, Wei-jiao, et al.
Publicado: (2022)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta
por: Li, QinJie, et al.
Publicado: (2022)

Potential Retinal Biomarkers in Alzheimer’s Disease
por: García-Bermúdez, Mariana Yolotzin, et al.
Publicado: (2023)

Biomarkers for the Clinical Diagnosis of Alzheimer’s Disease: Metabolomics Analysis of Brain Tissue and Blood
por: Wang, Yang-Yang, et al.
Publicado: (2021)

Altered Regional Cerebral Blood Flow and Brain Function Across the Alzheimer's Disease Spectrum: A Potential Biomarker
por: Zhang, Qianqian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_psb66kgeuc6ur0tg5l8ld431v4